Biostar Pharmaceuticals, Inc. (BSPM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|
| Revenue | 2.38 Million | 27.12 Million | 61.41 Million | 52.72 Million | 49.31 Million | 91.96 Million |
| Cost of Revenue | 1.46 Million | 16.02 Million | 31.14 Million | 27.04 Million | 19.46 Million | 27.57 Million |
| Gross Profit | 915.17 Thousand | 11.1 Million | 30.27 Million | 25.68 Million | 29.85 Million | 64.38 Million |
| Operating Expenses | 4.47 Million | 21.97 Million | 28.97 Million | 24.6 Million | 41.99 Million | 46.22 Million |
| Selling, General and Administrative Expenses | 3.6 Million | 13.28 Million | 26.2 Million | 22.66 Million | 33.84 Million | 43.9 Million |
| Research and Development Expenses | 1.14 Million | 4.02 Million | 2.76 Million | 3.22 Million | 4.47 Million | 2.32 Million |
| Other Expenses | -265.48 Thousand | 4.66 Million | 67.00 | -1.29 Million | 3.67 Million | - |
| Cost and Expenses | 5.94 Million | 38 Million | 60.11 Million | 51.65 Million | 61.45 Million | 73.8 Million |
| Operating Income | -3.56 Million | -10.87 Million | 2.63 Million | 2.42 Million | -12.14 Million | 18.15 Million |
| Interest Expense | 206.19 Thousand | 283.59 Thousand | 154.54 Thousand | 367.49 Thousand | 84.38 Thousand | 41.94 Thousand |
| Income Tax Expense | 2.65 Million | 1.31 Million | -3.31 Million | 1.84 Million | -1.57 Million | 5.89 Million |
| Earnings before Tax | -3.04 Million | -23.79 Million | 1.53 Million | 2.65 Million | -21.57 Million | 18.06 Million |
| Net Income | -5.69 Million | -25.11 Million | 4.84 Million | 809.04 Thousand | -19.99 Million | 12.17 Million |
| Earnings Per Share Basic | -2.48 | -11.36 | 2.30 | 0.49 | -14.63 | 9.17 |
| Earnings Per Share Diluted | -2.48 | -11.36 | 2.30 | 0.49 | -14.63 | 9.17 |
| Weighted Average Shares Outstanding | 2.29 Million | 2.21 Million | 2.07 Million | 1.64 Million | 1.36 Million | 1.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.29 Million | 2.21 Million | 2.07 Million | 1.64 Million | 1.36 Million | 1.32 Million |
| Gross Margin | 0.38 | 0.41 | 0.49 | 0.49 | 0.61 | 0.70 |
| EBIT Margin | -0.81 | -0.32 | 0.09 | 0.10 | -0.20 | 0.21 |
| Profit Margin | -2.39 | -0.93 | 0.08 | 0.02 | -0.41 | 0.13 |
| EBITDA | -1.69 Million | -21.18 Million | 4.39 Million | 3.53 Million | -21.48 Million | 18.99 Million |
| Earnings Before Tax Margin | -1.49 | -0.40 | 0.04 | 0.05 | -0.25 | 0.20 |
| Breakdown | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 FY | 2016 Q4 | 2016 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2.38 Million | 317.79 Thousand | 644.93 Thousand |
| Cost of Revenue | - | - | - | 1.46 Million | 354.54 Thousand | 336.87 Thousand |
| Gross Profit | - | - | - | 915.17 Thousand | -36.74 Thousand | 308.06 Thousand |
| Operating Expenses | 573.38 Thousand | 1.52 Million | 986.3 Thousand | 4.47 Million | -5.96 Million | 2.27 Million |
| Selling, General and Administrative Expenses | 573.38 Thousand | 1.52 Million | 1.03 Million | - | 978.84 Thousand | 779.06 Thousand |
| Research and Development Expenses | - | - | - | - | 1.14 Million | - |
| Other Expenses | 482.46 Thousand | 110.00 | -53.49 Thousand | -265.48 Thousand | -8.08 Million | 1.49 Million |
| Cost and Expenses | 573.38 Thousand | 1.52 Million | 986.3 Thousand | 5.94 Million | -5.6 Million | 2.6 Million |
| Operating Income | -90.9 Thousand | -1.52 Million | -1.03 Million | -3.56 Million | 5.92 Million | -1.96 Million |
| Interest Expense | 47.2 Thousand | 45.9 Thousand | 45.71 Thousand | 206.19 Thousand | 62.47 Thousand | 105.4 Thousand |
| Income Tax Expense | 529.67 Thousand | 46.01 Thousand | 45.31 Thousand | 2.65 Million | 2.65 Million | 606.97 Thousand |
| Earnings before Tax | -125.18 Thousand | -1.31 Million | -1.01 Million | -3.04 Million | 6.04 Million | -1.56 Million |
| Net Income | -654.86 Thousand | -1.36 Million | -1.05 Million | -5.69 Million | 3.38 Million | -2.17 Million |
| Earnings Per Share Basic | -0.25 | -0.52 | -0.40 | - | 1.61 | -0.98 |
| Earnings Per Share Diluted | -0.25 | -0.52 | -0.40 | - | 1.61 | -0.98 |
| Weighted Average Shares Outstanding | 2.63 Million | 2.63 Million | 2.63 Million | 2.29 Million | 2.55 Million | 2.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.63 Million | 2.63 Million | 2.63 Million | 2.29 Million | 2.55 Million | 2.21 Million |
| Gross Margin | - | - | - | 0.38 | -0.12 | 0.48 |
| EBIT Margin | - | - | - | - | 19.36 | -1.64 |
| Profit Margin | - | - | - | -2.39 | 10.66 | -3.37 |
| EBITDA | 209.34 Thousand | -1.24 Million | -687.57 Thousand | - | 6.15 Million | -1.05 Million |
| Earnings Before Tax Margin | - | - | - | -1.49 | 18.65 | -3.04 |
ANG
FMNB
RCOM
300173
ARQT
SMR-WT